HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two types of early epileptic encephalopathy in a Pitt-Hopkins syndrome patient with a novel TCF4 mutation.

AbstractINTRODUCTION:
Pitt-Hopkins syndrome (PTHS) is a neurodevelopmental disorder caused by mutations in TCF4. Seizures have been found to vary among patients with PTHS. We report the case of a PTHS patient with a novel missense mutation in the gene TCF4, presenting with two types of early epileptic encephalopathy.
CASE REPORT:
The patient was a Japanese boy. His first seizure was reported at 17 days of age, with twitching of the left eyelid and tonic-clonic seizures on either side of his body. An ictal electroencephalogram (EEG) showed epileptic discharges arising independently from both hemispheres, occasionally resembling migrating partial seizures of infancy (MPSI) that migrated from one side to the other. Brain magnetic resonance imaging revealed agenesis of the corpus callosum. His facial characteristics included a distinctive upper lip and thickened helices. His seizures were refractory, and psychomotor development was severely delayed. At the age of 10 months, he developed West syndrome with spasms and hypsarrhythmia. After being prescribed topiramate (TPM), his seizures and EEG abnormalities dramatically improved. Also, psychomotor development progressed. Whole-exome sequencing revealed a novel de novo missense mutation in exon 18 (NM_001083962.2:c.1718A > T, p.(Asn573Ile)), corresponding to the basic region of the basic helix-loop-helix domain, which may be a causative gene for epileptic encephalopathy.
CONCLUSIONS:
To our knowledge, this is the first report of a patient with PTHS treated with TPM, who presented with both MPSI as well as West syndrome. This may help provide new insights regarding the phenotypes caused by mutations in TCF4.
AuthorsHinako Kirikae, Mitsugu Uematsu, Yurika Numata-Uematsu, Naoya Saijo, Yu Katata, Yoshitsugu Oikawa, Atsuo Kikuchi, Kumiko Yanagi, Tadashi Kaname, Kazuhiro Haginoya, Shigeo Kure
JournalBrain & development (Brain Dev) Vol. 44 Issue 2 Pg. 148-152 (Feb 2022) ISSN: 1872-7131 [Electronic] Netherlands
PMID34579981 (Publication Type: Case Reports)
CopyrightCopyright © 2021 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Anticonvulsants
  • TCF4 protein, human
  • Transcription Factor 4
  • Topiramate
Topics
  • Anticonvulsants (pharmacology)
  • Facies
  • Humans
  • Hyperventilation (diagnosis, drug therapy, genetics, physiopathology)
  • Infant
  • Intellectual Disability (diagnosis, drug therapy, genetics, physiopathology)
  • Male
  • Mutation, Missense
  • Spasms, Infantile (diagnosis, drug therapy, genetics, physiopathology)
  • Topiramate (pharmacology)
  • Transcription Factor 4 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: